CIP Web Site: http://cip.cancer.gov/NIH - New Funding Initiatives
1. PATHOGENESIS AND TREATMENT OF LYMPHEDEMA AND LYMPHATIC DISEASES (NHLBI, NICHD, NIAMS, NCI, NCCAM, NIBIB, NINR) (PA-04-071 (see addendum NOT-HL-04-111
The NHLBI, and NCI and other institutes invite applications for research project grants to investigate the pathogenesis and new treatments for primary and secondary lymphedema, to stimulate research on the biology of the lymphatic system, to characterize at the molecular, cellular, tissue, organ, and intact organism levels, the pathophysiologic mechanisms that cause the disease, to develop new methods for quantitating and imaging lymph flow, to discover new therapeutic interventions, and to determine the safety, efficacy and mechanisms of action of complementary and alternative therapies.
2. 2004 SOLICITATION OF THE PUBLIC HEALTH SERVICE FOR SMALL BUSINESS INNOVATION RESEARCH CONTRACT PROPOSALS
The 2004 SBIR contract solicitation will be announced in late July or in August. There are topics of interest to companies which concern themselves with creation of radioactive materials or synthesis of radiopharmaceuticals. The 2003 announcement was issued August 28, 2003, and is at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-060.html.
The receipt data was 2 1/2 months after the announcement. Keep watching the NIH Guide for the announcement.
3. MIDCAREER INVESTIGATOR AWARD IN PATIENT-ORIENTED RESEARCH (K24) (PA-04-107)
The Midcareer Investigator Award in Patient-Oriented Research is to provide support for clinician investigators to allow protected time to devote to patient-oriented research (POR) and to act as research mentors primarily for clinical residents, clinical fellows and/or junior clinical faculty. This award is primarily intended for clinician investigators who are at the Associate Professor level and who have an established record of independent, peer-reviewed Federal or private research grant funding in POR.
4. ANNOUNCING THE HIGH PRIORITY, SHORT-TERM PROJECT AWARD (R56) (NOT-OD-04-047)
NIH announces the new NIH High Priority, Short-Term Project Award (R56). R56 grants will be awarded beginning in Fiscal Year 2005. The new R56 grant will fund, for one or two years, high-priority new or competing renewal R01 applications that fall just outside the limits of funding of the participating NIH Institutes and Centers. INVESTIGATORS MAY NOT APPLY FOR AN R56 GRANT.
5. NIH ROADMAP
The NIH Roadmap is an integrated vision to deepen our understanding of biology, stimulate interdisciplinary research teams, and reshape clinical research to accelerate medical discovery and improve people's health. Most of the initiatives will begin in FY 2004. Other initiatives will start in FY 2005 and beyond, depending upon the budget and other emerging needs. The three NIH Roadmap themes are as follows: new pathways to discovery, research teams of the future, and re-engineering the clinical research Enterprise.
6. MOLECULAR LIBRARIES SCREENING INSTRUMENTATION (ROADMAP)(RFA-RM-04-020)
LETTER OF INTENT RECEIPT DATE: September 22, 2004
APPLICATION RECEIPT DATE: October 22, 2004
The NIH invites research applications to develop innovative instrumentation to accelerate the pace and maximize the efficiency of molecular library high throughput screening. Investigators are encouraged to collaborate, as appropriate, with investigators working on assay development and on establishment of screening centers for the Molecular Libraries and Imaging Initiative. Applications in response to this RFA should propose design-directed, discovery-driven, or hypothesis-driven research on high throughput screening instrumentation.
7. NANOMEDICINE CENTER CONCEPT DEVELOPMENT AWARDS (NIH) (RFA-RM-04-018)
Receipt Date: July 26, 2004
This RFA has two purposes:
- Part 1 - describes a new initiative to support a network of Nanomedicine Development Centers. This part of the RFA includes a description of an emerging NIH vision of Nanomedicine and the scientific basis driving this initiative.
- Part 2 - presents a solicitation of applications, or more aptly, "white papers," for applicants to request support for planning the Nanomedicine Development Centers.
8. NCI DEVELOPING CRITERIA FOR $200 MILLION LOAN PROGRAM FOR CANCER CENTERS
The Medicare Modernization Act of 2003, approved last year by the Congress, provides $200 million, in Sec. 1016. Health care infrastructure improvement program for funding, for loans to hospitals engaged in research in the causes, prevention and treatment of cancer, and designated as a cancer center by the NCI or designated by the state as an official cancer institute of the state, for improving the healthcare infrastructure of the hospital, including construction, renovation, or other capital improvements. It is not known how this loan funding will be administered. The full text of the act can be found on the CMS website.
URL: http://www.cms.hhs.gov/medicarereform/ Announcements
JOB ANNOUNCEMENT: IMAGING SCIENTIFIC EDITOR - NIH IMAGING AGENT DATABASE
ComputerCraft Corporation, Bethesda, Maryland, posted May 26, 2004
Computercraft seeks an experienced imaging scientist / editor to provide scientific leadership in the development and maintenance of a new imaging database project at the National Institutes of Health. The individual will work with NIH staff scientists and extramural advisors onsite at the NIH campus. This diversified and challenging position requires a Ph.D. (strongly preferred) or M.S. degree in imaging sciences or highly related field; additional post-Doctoral or post-Master laboratory experience is desired. For consideration please submit cover letter, resume/CV, salary history, salary requirements, and U.S. employment eligibility (you must currently reside in the U.S. and be eligible to work). Contact Computercraft for details.
; Fax: 301-493-1288
Mail: Computercraft, Attn: HR, 6701 Democracy Blvd., Suite 401, Bethesda, Maryland 20817
SCIENTIFIC CURATOR - NIH IMAGING AGENT DATABASE
Computercraft seeks an experienced imaging scientist to provide curatorial responsibilities for implementing and maintaining the NIH imaging agent database. The individual will work with NIH staff scientists and extramural advisors onsite at the NIH campus. Join our team of highly skilled and dedicated professionals as we participate in the development of a new centralized database of in vivo
imaging agents. This innovative database will include agents developed for position-emission tomography (PET), single-photon emission computed tomography (SPECT), magnetic resonance imaging (MRI), ultrasound and optical imaging. The database will be located within the National Center for Biotechnology Information (NCBI) at the National Institutes of Health (NIH). This diversified and challenging position requires a Ph.D. (strongly preferred) or M.S. degree in imaging sciences or highly related field. The successful candidate will have a demonstrable knowledge of the chemistry and developmental process of in vivo
imaging agents, experience with current analytical tools in both chemistry and biology, and a working knowledge of the issues associated with the information technology and cheminformatics required to successfully implement this database. The ability to extract and summarize scientific information in a textual format is essential. Contact Computercraft for details.
; Fax: 301-493-1288
Mail: Computercraft, Attn: HR, 6701 Democracy Blvd., Suite 401, Bethesda, Maryland 20817
PET ENGINEER / PHYSICIST - PET DEPARTMENT, NATIONAL INSTITUTES OF HEALTH
A research support position is available in the PET Department at the National Institutes of Health. In the very near future, the Department will be installing a new state-of-the-art High Resolution Research Tomograph (HRRT) from CTI PET Systems (CPS). This device will produce the highest resolution human PET brain images to date. The primary responsibilities of the engineer/physicist are the maintenance, trouble-shooting, and repair of the HRRT, in conjunction with NIH staff and CPS personnel. Interested individuals should apply online at:
CHANGE IN DIRECT COST LIMITATIONS ON SOLICITED APPLICATIONS (NIH) (NOT-OD-04-040)
NIH announces a revision of its policy on direct cost limitations on solicited applications published after this notice. Applications in response to those Program Announcements (PAs) and Requests for Applications (RFAs) that include a limitation on direct costs are to exclude from that limit the facilities and administrative (F&A) costs requested by consortium participants.
NIH POLICY ON SHARING OF MODEL ORGANISMS FOR BIOMEDICAL RESEARCH (NOT-OD-04-042)
NIH is committed to supporting efforts that encourage the sharing and dissemination of important research resources. This notice reaffirms NIH support for the concept of timely sharing and distribution of biomedical research resources; it applies to extramural investigators funded by NIH grants, cooperative agreements, and contracts, including SBIR and STTR awards. All investigators submitting an NIH application or contract proposal beginning with the October 1, 2004 receipt date are expected to include in the application/proposal a description of a specific plan for sharing and distributing unique model organism research resources generated using NIH funding OR state appropriate reasons for why such sharing is restricted or not possible.
CREATING CANCER NANOTECHNOLOGY PLATFORMS THROUGH DIRECTED RESEARCH PROGRAMS: REQUEST FOR INFORMATION (RFI) (NOT-CA-04-022)
Responses due by August 2, 2004
The National Cancer Institute (NCI) is interested in attracting ideas for directed research programs that will ultimately deploy nanotechnology platforms for the diagnosis or treatment of cancer. Areas for consideration may include, but are not limited to: Early imaging agents and diagnostics that will allow clinicians to detect cancer in its earliest, most easily treatable, presymptomatic stage; other area ideas follow. For further information on this or other NCI nanotechnology initiatives, please see http://otir.cancer.gov
or contact the Office of Technology and Industrial Relations.
CSR REVIEW PANELS REORGANIZED
The NIH Center for Scientific Review has reorganized the review panels to which the investigator-initiated imaging applications are sent. BMIT is the former DMG; MEDI is the former RNM Look at the web site to see the Surgical Sciences, Biomedical Imaging, and Bioengineering IRB (SBIB) information with links to the Study Sections
NIH GRANTS POLICY STATEMENT (REV. 12/03): CORRECTION to INVENTION, LICENSING AND PATENT COSTS (NOT-OD-04-045)
The purpose of this Notice is to correct the statement on the allowability of invention, licensing and patent costs under Part II "Terms and Conditions of NIH Grant Awards, Cost Considerations, Selected Items of Cost, Invention, Patent, or Licensing Costs" that is included in the revised NIH Grants Policy Statement (NIHGPS, rev. 12/03) located at http://grants.nih.gov/grants/policy/nihgps_2003/NIHGPS_Part6.htm#inv
CIP DCIDE PROGRAM
The Cancer Imaging Program of the NCI requests submissions for its Development of Clinical Imaging Drugs and Enhancers (DCIDE) initiative. The goal is the rapid movement of promising, novel cancer imaging enhancers or molecular probes from the laboratory to proof of principle clinical trials. See the web site for details.
The NIH Commons web site allows all NIH grantee organizations to interact with grants data, to check the status of grant applications, including viewing scores and summary statements when they are ready, and to submit progress reports on line, among a number of functions. Applicants and grants administrators should become familiar with the Commons.
SECOND AAPM WORKSHOP ON GRANTSMANSHIP
Friday, July 30 at the Westin Convention Center Hotel in Pittsburgh $200, space is limited to 30 participants; to reserve seating, send email along with a brief CV or biosketch (1-2 pages) to Sam Beddar at firstname.lastname@example.org
THIRD ANNUAL MEETING OF THE SOCIETY FOR MOLECULAR IMAGING
September 9-12, 2004, Adam's Mark Hotel, St. Louis, MO.
5TH INTERNATIONAL SYMPOSIUM ON RADIOHALOGENS (5ISR)
September 11-15, 2004, Whistler BC, Canada from Sept. 11-15th.
FOURTH INTER-INSTITUTE WORKSHOP ON OPTICAL DIAGNOSTIC IMAGING FROM BENCH TO BEDSIDE
National Institutes of Health, 20-22 September 2004, Natcher Auditorium, National Institutes of Health, Bethesda, Maryland
AGA/NIH SYMPOSIUM ON ADVANCED IMAGING AND TECHNOLOGY IN GASTROINTESTINAL NEOPLASIA
October 4-5, 2004, Bethesda Marriott, Bethesda, MD
HIGH-THROUGHPUT TECHNOLOGIES FOR IN VIVO
November 9-10, 2004, Watergate Hotel, Washington, DC
SIXTH NATIONAL FORUM ON BIOMEDICAL IMAGING IN ONCOLOGY
February 3-4, 2005, at the Bethesda Hyatt
SPIE MEDICAL IMAGING 2005
February 12-17, 2005; San Diego
Look for special meetings on Image Database and NIH Funding, as well as a track on Virtual Colonoscopy.
The Cancer Imaging Program at NCI has created this e-mail distribution list to notify interested people about funding opportunities and other issues related to imaging research. Its primary purpose is to call your attention to important, relevant information on NIH Web pages, or in the NIH Guide. Occasionally it may be used to clarify areas of confusion, or disseminate answers to frequently asked questions.
If you wish to remain on the list, no action is necessary. If you wish to be added to the list (or removed from it), please contact Ms. Johnnie Smith by return e-mail (email@example.com
Cancer Imaging Program
Division of Cancer Treatment and Diagnosis, NCI
EPN, Room 6000 - MSC-7412
6130 Executive Boulevard
Bethesda, MD 20892-7412
Tel: 301 496 9531
Fax: 301 480 3507